Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.66
(
-1.08%
)
Bitcoin
74,331.91
(
0.64%
)
News Focus
News Focus
Post# of 821992
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ilovetech

Send PM Follow Ignore
Followers 119
Posts 9710
Boards Moderated 0
Alias Born 02/03/2018

ilovetech

Member Level

Re: Lykiri post# 790325

Monday, 09/29/2025 1:27:54 PM

Monday, September 29, 2025 1:27:54 PM

Post# of 821992
Lykiri - BP's benefit from having a
stacked advisory committee filled with panelists with former ties to the applicant.
I have the mRNA advisory panel (Zoom recorded minutes) consisting of 12 advisors, "all" with former ties to Pfizer.

Reply from George Zavoico.

But given that our technology is a first-in-class and innovative cell therapy that the MHRA has never seen before it appears they are being extra careful in their review. I conclude that given our active engagement with them, every day that passes is a day closer to their decision.



I'll leave it there.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News